Dear Pharmacist:
`
`Thank you for registering to dispense THALOMID" (fllalidornide). Your registration card has been received and
`processed, and your phannacy is new registered in the System for Thalidomide Education and Prescribing Safety
`(S. 3lZE.P.S.) Pharmacy Registry. You will receive patient registration forms that must be completed for every _
`new patient receiving TI-IALOMID" (thalidomide) with your first TH.ALOMID""(thalidomide) shipment
`. Yourpharmacy may now dispense prescriptions for_TI-IALOMIDT"(ti1aiiclomide),'aocordingto the following
`procedures:
`_
`-
`Dispensing initial prescriptions:
`
`'
`
`.
`
`'
`
`_
`
`.
`
`" '
`
`_ .
`-
`-
`
`._
`
`
`- Do not dispense ifprescription was written more than 14 days prior. ._
`'
`-. Collect and retain a signed infornied consent form.
`'
`I
`— If the patient does not present a completed informed consent form with-the prescription,
`'_
`-
`'
`the physician must he notified that the forth is mandatory for a prescription to be filled.
`— _-."I'he h sician can order‘ _
`uired S. T.E.P.5'.
`to
`materials by calling 1'—s‘ss-4-CELGENE.
`_
`-
`- . Enroll the patientinthe-S1fI.E'.P..S‘. Patient Regisinr.
`_
`-
`'
`-
`-'
`-'
`-'
`-
`—.
`' Complete the patien'tregistration form andsupply the__ii1foi1i1ation by
`l-838-4-C1_iLGEl*lE, orby -
`fax to-1-ss3-475-2c'rr2-. ;
`.
`.;.
`‘ Dispense no’morethan a'4-w_ee'lt
`supply ofTHAL(IT)-1'Vfll)".'(thaIidoit1Lide)‘
`I
`'2_°.nt_onm‘c refill p’rescrippions are not.per_nu'tted
`_
`'
`Dispensingsubseqnentpreseriptions:
`-
`I
`-
`Telgplioneprescripfionsarepeitnitted;
`-
`Do not dispense ifprescription was wri__tter'1 inoie than '14 daze prio1_-.‘_‘_- _.
`_ .'
`'
`'1.
`.Verify patient reg'ist1'y'and record subsequent prescriptions.
`- —
`Patientenro1ln1ci1tstatusn1ustbeverifiedvi§'oii'=flhe " ' missi_o_nIB_1N 6'1o5s4 Processor canes; BB1,
`Submitted Group Thal_idom,ide) orb} calling l-888-4-C\ELGEl§~EE;_
`.
`'
`'
`'
`'
`._- Do_notdispense:'I"HALOMID"’ (tlialidornide) ifimorethanffdays-remain on the
`prescription.
`fr-_
`.
`"Q"
`' Qispgu§'§_-pp" more thana4-week(2§-da\{}_supp._1g.
`-
`--
`'
`.
`'-
`.'
`-
`.
`I
` mide hlister
`acl-in esntust be dis eased intact. Tlaeca
`tiles"cnii'not"'
`'TirAL01\«ni)“'
`tlialido
`
`__
`.. p'e.rep'ackagi:'d.
`'-
`_
`_
`_
`_
`_
`_
`_
`.
`_
`as :
`A Ihonogra'ph
`infomiation
`‘well-as prescribing and dispetising guide
`I
`_lines,'1will_'b_e provideci_t,o yon: This monograph is approved for continu-
`'_
`.
`. ing phannaceuticsl education credits upon completion.
`for-_.
`fI‘o‘reorder eddifioihil patient registiration fci1"-nine", oijjfyou hai.re_'question_s about
`_ dispensing rH.r=t_1._oM113*f'g;g:11‘a1ido:_ni&1e),p_1».§a;e_ca1_11:333-4-csttssnjs,oiraxyoui-inquiry pa 1_;'sss-47_s-2e72.-
`1_ftnn1:'you fo1_"I_1jc_'l.ping' rniijéelcertnin tliat__’_f‘HALOM1D“‘ (tlialidpn1_id_§:)_ is |1iade_{1v:'til:fc'1l"il.é_tt:o"3.roIi1r'1i7-Iaitiients in the .'
`"rnostre'sp_on_sihl_e_fashion. ‘enc]ose_d.f_ul1Prpsci'ibing_ 1nfon11:a“t.it'_)r1.-_:J.3__'.
`._' H .‘ __‘_
`I-._
`-._
`_'
`-.
`.. . i
`-
`
`.
`
`'
`
`_
`
`_
`
`" _
`
`_
`
`_
`
`.'vicePresident,.Direct"_rofmarkerixis
`
`-
`
`'-
`
`_
`
`-
`
`~
`
`=
`
`-'-:-«'
`
`Enclousure - _ I 1‘ ‘
`P'a”ge'4 9ft.
`H
`,
`in'Case'.lPl§2'015L(l11:03_‘‘ 5-1 5 "
`
`'
`
`T _C‘l'-Z_l_.‘.GEN'E EXHIBIT 2o_s4 .‘
`
`Page 1 of 1
`
`Case IPR2015-01103
`
`CELGENE EXHIBIT 2064